InterMune
ABOUT USPRODUCTSPIPELINEINVESTOR RELATIONSNEWSCAREERS





Analyst Coverage

Annual Reports

E-mail Alerts

Event Calendar

Information Request

Insider Trading

SEC Filings

Stock Information

Stock Quote
ITMN (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$38.02
Change (%) Stock is Up 14.72 (63.18%)
Volume14,466,171
Data as of 03/10/10 3:34 p.m. ET
Minimum 20 minute delay
Refresh quote
Slide Presentations
These presentations are intended for investors and analysts for financial purposes and are not intended for health care practitioners. Health care practitioners with questions regarding these presentations are referred to InterMune Medical Information at 1(888) 486-6411.
ITMN-191 Presentation at HepDart, December 6, 2009
INFORM-1 presentation at AASLD, November 3, 2009
CAPACITY Results at ERS, September 2009
ITMN-191 Phase 1b triple combination presentation from EASL, April 2009
CAPACITY results conference call, February 2009
Webcast ImageWebcast - Replay
InterMune Inc. Conference Call to Discuss Outcome of FDA Advisory Committee
03/09/10 at 5:00 p.m. ET
Webcast ImageWebcast - Replay
Q4 2009 Earnings Conference Call
02/17/10 at 4:30 p.m. ET
Webcast ImageWebcast - Replay
InterMune Inc. at JPMorgan Healthcare Conference
01/13/10 at 4:00 p.m. PT
Webcast ImageWebcast - Replay
InterMune Inc. at Deutsche Bank Securities Biotech Boston Confab Conference
12/15/09 at 9:30 a.m. ET
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever InterMune posts new information to the site. Just enter your e-mail address and click Submit.
Enter your e-mail address here:
Recent NewsMore >>
DateTitle 
03/09/10FDA Advisory Committee Recommends Approval of InterMune's Esbriet(R) (pirfenidone) for Idiopathic Pulmonary FibrosisPrinter Friendly Version
03/09/10InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory CommitteePrinter Friendly Version
03/09/10Trading Halted Today in InterMune Common StockPrinter Friendly Version
03/05/10InterMune Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on PirfenidonePrinter Friendly Version
Transfer Agent
Mellon Investor Services LLC
525 Market Street, Suite 3500
San Francisco, CA 94105
Phone: 877-854-4572
(Dedicated number for InterMune)

Fax: 415-951-4181
www.bnymellon.com/shareowner/isd
Independent Accountants
Ernst & Young LLP

Nothing on this website constitutes or is intended to constitute an invitation or offer to invest or deal in the securities of Intermune.

Except for the historical information contained herein, this website contains certain forward-looking statements that involve risks and uncertainties. You can identify those statements by the fact that they contain words such as "anticipate," "believe," "estimate," "expect," "potential," "intend," "project," or other terms of similar meaning. InterMune’s actual results may differ materially from those described in the forward-looking statements. All forward-looking statements and other information included in this website are based on information available to InterMune as of July 15, 2004, and InterMune assumes no obligation to update any such forward-looking statements or information. Factors that could cause or contribute to such differences include, but are not limited to, those discussed under the heading "Risk Factors" and the other risks and factors discussed in InterMune’s most recent Form 10-K and other periodic filings (i.e., 8-K and 10-Q) filed with the Securities and Exchange Commission. The SEC’s website is http://www/sec/gov, and our filings are contained in the SEC’s Edgar archives. Please see the Terms and Conditions of Access and Use section of this website for a listing of InterMune’s "Risk Factors," which are discussed in the periodic filings filed with the SEC.


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.



   © InterMune 2010  |  Terms and Conditions  |  Privacy Policy
 HOME 
 CONTACT US 
 SITE MAP   SEARCH